Jay Venkatesan is of Angion Biomedica Corp.. Currently has a direct ownership of 1.89 Million shares of ANGN, which is worth approximately $0. The most recent transaction as insider was on May 25, 2022, when has been sold 11,313 shares (Common Stock) at a price of $1.25 per share, resulting in proceeds of $14,141. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.89M
0% 3M change
0% 12M change
Total Value Held $0

Jay Venkatesan Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 25 2022
BUY
Open market or private purchase
$14,141 $1.25 p/Share
11,313 Added 0.59%
1,891,947 Common Stock
May 24 2022
BUY
Open market or private purchase
$39,928 $1.24 p/Share
32,200 Added 1.84%
1,721,457 Common Stock
May 20 2022
BUY
Open market or private purchase
$61,500 $1.23 p/Share
50,000 Added 2.87%
1,689,257 Common Stock
Dec 28 2021
BUY
Open market or private purchase
$559,496 $2.66 p/Share
210,337 Added 11.37%
1,639,257 Common Stock
Dec 27 2021
BUY
Open market or private purchase
$170,613 $2.55 p/Share
66,907 Added 4.47%
1,428,920 Common Stock
Dec 20 2021
BUY
Open market or private purchase
$8,959 $2.54 p/Share
3,527 Added 0.26%
1,362,013 Common Stock
Dec 17 2021
BUY
Open market or private purchase
$34,905 $2.54 p/Share
13,742 Added 1.0%
1,358,486 Common Stock
Dec 16 2021
BUY
Open market or private purchase
$71,102 $2.55 p/Share
27,883 Added 2.03%
1,344,744 Common Stock
Dec 15 2021
BUY
Open market or private purchase
$187,026 $2.41 p/Share
77,604 Added 5.57%
1,316,861 Common Stock
Jun 24 2021
SELL
Payment of exercise price or tax liability
$566,234 $13.78 p/Share
41,091 Reduced 3.21%
1,239,257 Common Stock
Feb 09 2021
SELL
Open market or private sale
$2,546,832 $16.0 p/Share
159,177 Reduced 11.64%
1,208,086 Common Stock
Feb 09 2021
SELL
Payment of exercise price or tax liability
$511,456 $16.0 p/Share
31,966 Reduced 2.99%
1,037,017 Common Stock
Feb 09 2021
BUY
Conversion of derivative security
$1,913,169 $11.57 p/Share
165,356 Added 11.44%
1,280,348 Common Stock
Feb 09 2021
BUY
Exercise of in-the-money or at-the-money derivatives securities
$1,524,887 $6.43 p/Share
237,152 Added 14.15%
1,439,263 Common Stock

Also insider at

ALPN
ALPINE IMMUNE SCIENCES, INC. Healthcare
JV

Jay Venkatesan

Seattle, WA

Track Institutional and Insider Activities on ANGN

Follow Angion Biomedica Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANGN shares.

Notify only if

Insider Trading

Get notified when an Angion Biomedica Corp. insider buys or sells ANGN shares.

Notify only if

News

Receive news related to Angion Biomedica Corp.

Track Activities on ANGN